Phylo is an applied research lab dedicated to studying agentic intelligence to accelerate discoveries for every biomedical scientist. Backed by a16z.
About the role
Phylo launched publicly on the back of a $13.5M seed round co-led by Andreessen Horowitz and Menlo Ventures/Anthropic. We have strong enterprise inbound, active deployments, and a growing pipeline of pharma and biotech teams adopting Biomni Lab. We have proven the motion. Now we are building the engine.
What they're looking for
- Proven track record closing enterprise deals in big pharma and biotech, ideally within R&D and the drug discovery process (target discovery, lead optimization, translational, and adjacent workflows)
- Working fluency with MEDDPICC (or a comparable methodology) and the discipline to run it consistently across a complex cycle
- Experience selling a consumption-based or usage-based platform, with command of the forecasting and expansion dynamics that come with it
- Strong scientific literacy: you can discuss experimental design, evaluate data sources, and hold your own with R&D and computational biology stakeholders. Background in biology, computational biology, or biomedical science strongly preferred
- Intellectual curiosity: you go deep on both the science and the technology, ask sharp questions, and keep learning in a field that is moving fast
- Comfort navigating long, multi-stakeholder enterprise cycles through technical champions, procurement, and senior economic buyers
More about this role
Phylo is an applied research lab building agentic intelligence to accelerate discovery for every biomedical scientist. We believe AI agents will fundamentally transform how biomedical research is done. Our fast-growing team brings together researchers and engineers across AI and biology, commercializing the Biomni platform.
Our growing team brings together world class researchers and engineers across AI and biology. Backed by a $13.5M seed round led by a16z, Menlo Ventures and Anthropic, and advised by Nobel Prize laureate and pioneering biologists, Phylo is building the next generation of AI systems for the life sciences.
Phylo launched publicly on the back of a $13.5M seed round co-led by Andreessen Horowitz and Menlo Ventures/Anthropic. We have strong enterprise inbound, active deployments, and a growing pipeline of pharma and biotech teams adopting Biomni Lab. We have proven the motion. Now we are building the engine.
This is an early quota-carrying seat on a commercial team that is being built deliberately. You will own a book of enterprise pharma and biotech accounts end to end and carry a number, while partnering with our GTM leader, founders, and scientists to convert real...
Browse similar: Startup jobs · Remote jobs